rs2407083
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_021098.3(CACNA1H):c.1668C>T(p.Pro556Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 1,546,556 control chromosomes in the GnomAD database, including 13,598 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 982 hom., cov: 34)
Exomes 𝑓: 0.13 ( 12616 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.57
Publications
4 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-1202118-C-T is Benign according to our data. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-1202118-C-T is described in CliVar as Benign. Clinvar id is 96002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.57 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.147 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.1629C>T | p.Pro543Pro | synonymous_variant | Exon 9 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.1629C>T | p.Pro543Pro | synonymous_variant | Exon 9 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.1668C>T | p.Pro556Pro | synonymous_variant | Exon 9 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000711442.1 | n.*1115C>T | non_coding_transcript_exon_variant | Exon 8 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.1668C>T | non_coding_transcript_exon_variant | Exon 9 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000711442.1 | n.*1115C>T | 3_prime_UTR_variant | Exon 8 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000640028.1 | n.1385+283C>T | intron_variant | Intron 9 of 34 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.101 AC: 15373AN: 152178Hom.: 980 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
15373
AN:
152178
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.115 AC: 16038AN: 140046 AF XY: 0.121 show subpopulations
GnomAD2 exomes
AF:
AC:
16038
AN:
140046
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.131 AC: 182907AN: 1394260Hom.: 12616 Cov.: 36 AF XY: 0.132 AC XY: 91019AN XY: 687576 show subpopulations
GnomAD4 exome
AF:
AC:
182907
AN:
1394260
Hom.:
Cov.:
36
AF XY:
AC XY:
91019
AN XY:
687576
show subpopulations
African (AFR)
AF:
AC:
1055
AN:
31528
American (AMR)
AF:
AC:
2204
AN:
35630
Ashkenazi Jewish (ASJ)
AF:
AC:
1840
AN:
25106
East Asian (EAS)
AF:
AC:
1505
AN:
35668
South Asian (SAS)
AF:
AC:
12445
AN:
79166
European-Finnish (FIN)
AF:
AC:
6982
AN:
45878
Middle Eastern (MID)
AF:
AC:
540
AN:
5690
European-Non Finnish (NFE)
AF:
AC:
149473
AN:
1077734
Other (OTH)
AF:
AC:
6863
AN:
57860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
11023
22046
33070
44093
55116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5422
10844
16266
21688
27110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.101 AC: 15369AN: 152296Hom.: 982 Cov.: 34 AF XY: 0.103 AC XY: 7634AN XY: 74468 show subpopulations
GnomAD4 genome
AF:
AC:
15369
AN:
152296
Hom.:
Cov.:
34
AF XY:
AC XY:
7634
AN XY:
74468
show subpopulations
African (AFR)
AF:
AC:
1561
AN:
41584
American (AMR)
AF:
AC:
1294
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
217
AN:
3470
East Asian (EAS)
AF:
AC:
325
AN:
5166
South Asian (SAS)
AF:
AC:
755
AN:
4828
European-Finnish (FIN)
AF:
AC:
1665
AN:
10618
Middle Eastern (MID)
AF:
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9222
AN:
68008
Other (OTH)
AF:
AC:
233
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
731
1462
2192
2923
3654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
388
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Jul 05, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 22, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.